<SEC-DOCUMENT>0001387131-16-005907-index.html : 20160627
<SEC-HEADER>0001387131-16-005907.hdr.sgml : 20160627
<ACCEPTANCE-DATETIME>20160627165305
ACCESSION NUMBER:		0001387131-16-005907
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160411
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160627
DATE AS OF CHANGE:		20160627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adamis Pharmaceuticals Corp
		CENTRAL INDEX KEY:			0000887247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820429727
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36242
		FILM NUMBER:		161733862

	BUSINESS ADDRESS:	
		STREET 1:		11455 EL CAMINO REAL
		STREET 2:		SUITE 310
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 997-2400

	MAIL ADDRESS:	
		STREET 1:		11455 EL CAMINO REAL
		STREET 2:		SUITE 310
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELLEGY PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950615
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>admp-8k_041116.htm
<DESCRIPTION>AMENDED CURRENT REPORT
<TEXT>
Document 1 - file: admp-8k_041116.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<DESCRIPTION>CONSENT OF PUBLIC ACCOUNTING FIRM
<TEXT>
Document 2 - file: ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<DESCRIPTION>FINANCIAL STATEMENTS LISTED IN ITEM 9.01(A)
<TEXT>
Document 3 - file: ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ex99-2.htm
<DESCRIPTION>PRO FORMA FINANCIAL INFORMATION LISTED IN ITEM 9.01(B)
<TEXT>
Document 4 - file: ex99-2.htm

</DOCUMENT>
</SEC-DOCUMENT>